plerixafor has been researched along with Leukemia, Pre-B-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Q; Liu, P; Ma, D; Ni, M; Pan, C; Wang, J; Zhang, S | 1 |
| Amorim, M; Colmone, A; Jablonski, E; Pontier, AL; Sipkins, DA; Wang, S | 1 |
| Groffen, J; Heisterkamp, N; Lim, M; Lyu, MA; Parameswaran, R; Rosenblum, MG; Yu, M | 1 |
| Bendall, LJ; Bradstock, KF; Gottlieb, DJ; Juarez, J | 1 |
4 other study(ies) available for plerixafor and Leukemia, Pre-B-Cell
| Article | Year |
|---|---|
Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
Topics: Benzylamines; Cancer-Associated Fibroblasts; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Disease Progression; Humans; Mesenchymal Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Pyrazoles; Pyrroles; Receptors, CXCR4; Signal Transduction; Transforming Growth Factor beta; Tumor Microenvironment | 2020 |
Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.
Topics: Animals; Antigens, CD34; Benzylamines; Bone Marrow; Cell Count; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukemia, Myeloid, Acute; Mice; Mice, SCID; Neoplasm Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Factor; Stem Cell Niche; Transplantation, Heterologous; Tumor Cells, Cultured | 2008 |
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
Topics: Animals; Antineoplastic Agents; Apoptosis; B-Cell Activating Factor; Benzylamines; Bone Marrow; Cell Line, Tumor; Cyclams; Drug Synergism; Gene Expression Regulation, Leukemic; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Mice, SCID; NF-kappa B; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Fusion Proteins; Ribosome Inactivating Proteins, Type 1; Toxins, Biological; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
Topics: Antineoplastic Agents; Benzylamines; Cell Division; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Coculture Techniques; Cyclams; Dexamethasone; Drug Synergism; Heterocyclic Compounds; Humans; Oligopeptides; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, CXCR4; Stromal Cells; Vincristine | 2003 |